Detalhe da pesquisa
1.
Using EGFR amplification to stratify recurrent glioblastoma treated with immune checkpoint inhibitors.
Cancer Immunol Immunother
; 72(6): 1893-1901, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-36707424
2.
The future of cancer immunotherapy for brain tumors: a collaborative workshop.
J Transl Med
; 20(1): 236, 2022 05 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-35606815
3.
Widely metastatic glioblastoma with BRCA1 and ARID1A mutations: a case report.
BMC Cancer
; 20(1): 47, 2020 Jan 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-31959133
4.
The CNS and the Brain Tumor Microenvironment: Implications for Glioblastoma Immunotherapy.
Int J Mol Sci
; 21(19)2020 Oct 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33027976
5.
Exploiting the Complexities of Glioblastoma Stem Cells: Insights for Cancer Initiation and Therapeutic Targeting.
Int J Mol Sci
; 21(15)2020 Jul 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-32722427
6.
MRI Radiomic Features to Predict IDH1 Mutation Status in Gliomas: A Machine Learning Approach using Gradient Tree Boosting.
Int J Mol Sci
; 21(21)2020 Oct 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-33121211
7.
Multiparametric MRI for Differentiation of Radiation Necrosis From Recurrent Tumor in Patients With Treated Glioblastoma.
AJR Am J Roentgenol
; 210(1): 18-23, 2018 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-28952810
8.
Planning TTFields treatment using the NovoTAL system-clinical case series beyond the use of MRI contrast enhancement.
BMC Cancer
; 16(1): 842, 2016 11 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-27809808
9.
Disparities in receipt of modern concurrent chemoradiotherapy in glioblastoma.
J Neurooncol
; 128(2): 241-50, 2016 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-26970981
10.
Tracking normalization of brain tumor vasculature by magnetic imaging and proangiogenic biomarkers.
Cancer Cell
; 11(1): 6-8, 2007 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-17222788
11.
Multiparametric Radiogenomic Model to Predict Survival in Patients with Glioblastoma.
Cancers (Basel)
; 16(3)2024 Jan 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38339340
12.
Multi-Parametric Radiomic Model to Predict 1p/19q Co-Deletion in Patients with IDH-1 Mutant Glioma: Added Value to the T2-FLAIR Mismatch Sign.
Cancers (Basel)
; 15(4)2023 Feb 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36831380
13.
A Phase I Trial of VEGF-A Inhibition Combined with PD-L1 Blockade for Recurrent Glioblastoma.
Cancer Res Commun
; 3(1): 130-139, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36968223
14.
YKL-40 and MMP-9 as serum markers for patients with primary central nervous system lymphoma.
Ann Neurol
; 70(1): 163-9, 2011 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-21391238
15.
Gemcitabine induced myositis in patients with pancreatic cancer: case reports and topic review.
J Neurooncol
; 106(1): 15-21, 2012 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-21811892
16.
U-Net Based Segmentation and Characterization of Gliomas.
Cancers (Basel)
; 14(18)2022 Sep 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-36139616
17.
Phase I/randomized phase II trial of TRC105 plus bevacizumab versus bevacizumab in recurrent glioblastoma: North Central Cancer Treatment Group N1174 (Alliance).
Neurooncol Adv
; 4(1): vdac041, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35664553
18.
CD133 expression is not restricted to stem cells, and both CD133+ and CD133- metastatic colon cancer cells initiate tumors.
J Clin Invest
; 118(6): 2111-20, 2008 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-18497886
19.
Longitudinal prospective study of matrix metalloproteinase-9 as a serum marker in gliomas.
J Neurooncol
; 105(3): 607-12, 2011 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-21710351
20.
Multiparametric MRI texture analysis in prediction of glioma biomarker status: added value of MR diffusion.
Neurooncol Adv
; 3(1): vdab051, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34056604